JADO Technologies, a spin-out from the Max Planck Institute of Molecular Cell Biology and Genetics in Dresden, is developing small molecules that target cell membrane receptors, opening up a potential new avenue for drug delivery.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.